U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07914101) titled 'Sequential Chemotherapy Followed by Ultrahypofractionated Radiotherapy for Muscle-Invasive Bladder Cancer' on Sept. 26.
Brief Summary: Muscle-invasive bladder cancer (MIBC) is a potentially lethal disease for which radical cystectomy with appropriate systemic therapy remains a standard curative approach in medically fit patients. . However, Half of bladder cancer cases are diagnosed in patients aged over 75 years, many of whom are not fit for major surgery owing to their performance status and comorbidities .
A substantial proportion of bladder cancer cases occur in older adults (there is no single universal age cutoff for the term ...